HbA1c CONTROL LOW - India CDSCO Medical Device Registration

HbA1c CONTROL LOW is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2022/000042_e2a3e2e4b3b8ae1612caade0e8957183_c79bdf777a6cc20e6271b84e1224ebe8. This device is marketed under the brand name LIQUIXX -M- URIC ACID. The license holder is Transasia Bio-Medicals Limited, and it is classified as Device Class Class B. The approving authority is Solan(BBN).

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class B

HbA1c CONTROL LOW

UID: MFG/IVD/2022/000042_e2a3e2e4b3b8ae1612caade0e8957183_c79bdf777a6cc20e6271b84e1224ebe8

Brand Name

LIQUIXX -M- URIC ACID

License Holder

Transasia Bio-Medicals Limited

Device Class

Class B

Approving Authority

Solan(BBN)

Product Information

Hemoglobin HbA1c control set are intended for the use as an assayed quality control of quantitative HbA1c immunoturbidometric assay. For in - vitro diagnostic use only